492 related articles for article (PubMed ID: 12030437)
1. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
[TBL] [Abstract][Full Text] [Related]
2. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease.
Salmhofer W; Hermann J; Joch M; Kerl H; Graninger W
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123
[TBL] [Abstract][Full Text] [Related]
3. [Clinical expression of systemic lupus erythematosus with anti-U1-RNP and anti-Sm antibodies].
López-Longo FJ; González Fernández CM; Rodríguez Mahou M; Grau Simó R; Monteagudo Sáez I; Meno García AC; Carreño Pérez L
Rev Clin Esp; 1997 May; 197(5):329-35. PubMed ID: 9280966
[TBL] [Abstract][Full Text] [Related]
4. Anti-Sm and anti-RNP antibodies.
Migliorini P; Baldini C; Rocchi V; Bombardieri S
Autoimmunity; 2005 Feb; 38(1):47-54. PubMed ID: 15804705
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
Combe B; Rucheton M; Graafland H; Lussiez V; Brunel C; Sany J
Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772
[TBL] [Abstract][Full Text] [Related]
6. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
[TBL] [Abstract][Full Text] [Related]
7. Nonprecipitating IgG or IgM anti-Sm antibody: clinical significance and changes in immunoglobulin class.
Tsuzaka K; Ogasawara T; Tojo T; Mimori T; Satoh M; Homma M
J Rheumatol; 1993 May; 20(5):822-30. PubMed ID: 7687702
[TBL] [Abstract][Full Text] [Related]
8. Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens.
Habets WJ; Berden JH; Hoch SO; Van Venrooij WJ
Eur J Immunol; 1985 Oct; 15(10):992-7. PubMed ID: 2414112
[TBL] [Abstract][Full Text] [Related]
9. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
Molden DP; Suzuki H; Nakamura RM
Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.
Habets WJ; de Rooij DJ; Hoet MH; van de Putte LB; van Venrooij WJ
Clin Exp Immunol; 1985 Feb; 59(2):457-66. PubMed ID: 3884199
[TBL] [Abstract][Full Text] [Related]
12. Antiribonucleoprotein antibodies in children with human immunodeficiency virus infection: comparative study with childhood-onset systemic lupus erythematosus.
González CM; López-Longo FJ; Monteagudo I; Grau R; Rodríguez-Mahou M; St-Cyr C; Lapointe N; Carreño L
Pediatr AIDS HIV Infect; 1996 Dec; 7(6):401-8. PubMed ID: 11361496
[TBL] [Abstract][Full Text] [Related]
13. Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens.
Habets WJ; Hoet MH; Sillekens PT; De Rooij DJ; Van de Putte LB; Van Venrooij WJ
Clin Exp Immunol; 1989 May; 76(2):172-7. PubMed ID: 2527098
[TBL] [Abstract][Full Text] [Related]
14. Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus.
López-Longo FJ; Monteagudo I; González CM; Moreno AC; Rodríguez Mahou M; Grau R; Carreño L
J Rheumatol; 1998 Sep; 25(9):1743-9. PubMed ID: 9733455
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus.
Homma M; Mimori T; Takeda Y; Akama H; Yoshida T; Ogasawara T; Akizuki M
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():188-93. PubMed ID: 2441045
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
Faria AC; Barcellos KS; Andrade LE
J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
Margaux J; Hayem G; Palazzo E; Chazerain P; De Bandt M; Haim T; Kahn MF; Meyer O
Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.
Burdt MA; Hoffman RW; Deutscher SL; Wang GS; Johnson JC; Sharp GC
Arthritis Rheum; 1999 May; 42(5):899-909. PubMed ID: 10323445
[TBL] [Abstract][Full Text] [Related]
20. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
Lundberg I; Hedfors E
J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
